Understanding how bloating works with GLP-1 agonists can help you anticipate and prevent the diarrhea that follows it
Glucagon-like peptide-1 (GLP-1) Levels after MBS Besides dietary nonadherence and physical inactivity, psychiatric, anatomical, genetic, and hormonal causes are suggested to be underlying reasons for WR or IWL post MBS [1, 7]
This dual action provides enhanced appetite suppression and metabolic effects, leading to greater weight loss compared to Semaglutides single-receptor action
Some of the biggest questions I hear from my perinatal clients are about GLP-1 use in pregnancy, postpartum and fertility
FASEB J 12:5765
Helpful resources These foundational tools and guides support peptide education and protocol planning: May your healing stay accelerated, your muscle stay preserved, and your weight loss journey stay successful